, a provider of at-home health tests and nutritional supplements, is exploring a sale, according to people familiar with the matter.as it fields interest from other companies and private equity firms, the sources said.
Thorne's shares are up 45% year-to-date, outperforming an 18% rise in the S&P 500 Index and giving it a stock market value of around $300 million. The sources, who asked not to be identified because the matter is confidential, added that no deal is certain. A Thorne spokesperson said the company does not comment on rumors or speculation. CG Sawaya did not respond to requests for comment.
Founded in 1984, Thorne listed on the stock market in 2021 after it acquired Onegevity, a health analytics platform co-founded by Thorne Chief Executive Paul Jacobson. The company provides at-home health tests to assess - and supplements to aid - sleep, fertility, stress, gut health and other areas to create a personalized wellness plan. It sells its products directly to consumers, rather than relying on retailers and e-commerce firms.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
VCs name the most promising healthtech startups in 2023Insider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Source: BusinessInsider - 🏆 729. / 51 Read more »